Complement receptor type 1 (CR1, CD35) is a receptor for C1q

Immunity

Volumn 7, Issue 3, 1997, Pages 345-355

  Klickstein, Lloyd B ^a,b   Barbashov, Sergei F ^a   Liu, Tun ^a,d   Jack, Richard M ^c   Nicholson Weller, Anne ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c La Jolla Pharmaceutical Company   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3B RECEPTOR;

ARTICLE; DISSOCIATION CONSTANT; HUMAN; HUMAN CELL; MOLECULAR INTERACTION; MOLECULAR RECOGNITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RECEPTOR AFFINITY;

EID: 0030873970     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80356-8     Document Type: Article

References (73)

1. Arnaout, M.A., Melamed, J., Tack, B.F., and Colten, H.R. (1981). Characterization of the human complement (C3b) receptor with a fluid phase C3b dimer. J. Immunol. 127, 1348-1354.
2. Atkinson, J.P. (1986). Complement activation and complement receptors in systemic lupus erythematosus. Springer Semin. Immunopathol. 9, 179-194.
3. Baker, C.J., Edwards, M.S., Webb, B.J., and Kasper, D.L. (1982). Antibody-independent classical pathway-mediated opsonophagocytosis of Type Ia, group B Streptococcus. J. Clin. Invest. 69, 394-404.
4. Bleackley, R.C., Atkinson, E.A., Burns, K., and Michalak, M. (1995). Calreticulin: a granule-protein by default or design. Curr. Top. Microbiol. Immunol. 198, 145-159.
5. Bowness, P., Davies, K.A., Norsworthy, P.J., Athanassiou, P., Taylor-Wiedeman, J., Borysiewicz, L.K., Meyer, P.A., and Walport, M.J. (1994). Hereditary C1q deficiency and systemic lupus erythematosus. Q. J. Med. 87, 455-464.
6. Brown, E.J. (1989). The interaction of small oligomers of complement 3b (C3b) with phagocytes. High affinity binding and phorbol ester-induced internalization by polymorphonuclear leukocytes. J. Biol. Chem. 264, 6196-6201.
7. Changelian, P.S., Jack, R.M., Collins, L.A., and Fearon, D.T. (1985). PMA induces the ligand-independent internalization of CR1 on human neutrophils. J. Immunol. 134, 1851-1858.
8. Chen, A., Gaddipati, S., Hong, Y., Volkman, D.J., Peerschke, E.I.B., and Ghebrehiwet, B. (1994). Human Tcells express specific binding sites for C1q. Role in T cell activation and proliferation. J. Immunol. 153, 1430-1440.
9. Chevalier, J., and Kazatchkine, M.D. (1989). Distribution in clusters of complement receptor type one (CR1) on human erythrocytes. J. Immunol. 142, 2031-2036.
10. Colten, H.R., and Rosen, F.S. (1992). Complement deficiencies. Annu. Rev. Immunol. 10, 809-834.
11. Cullen, D.C., Brown, R.G., and Lowe, C.R. (1987). Detection of immuno-complex formation via surface plasmon resonance on gold-coated diffraction gratings. Biosensors 3, 211-225.
12. Dickler, H.B., and Kunkel, H.G. (1972). Interaction of aggregated gamma globulin with B lymphocytes. J. Exp. Med. 136, 191-196.
13. Edberg, J.C., Wright, E., and Taylor, R.P. (1987). Quantitative analyses of the binding of soluble complement-fixing antibody/dsDNA immune complexes to CR1 on human red blood cells. J. Immunol. 139, 3739.
14. Eggleton, P., Lieu, T.S., Zappi, E.G., Sastry, K., Coburn, J., Zaner, K.S., Sontheimer, R.D., Capra, J.D., Ghebrehiwet, B., and Tauber, A.I. (1994). Calreticulin is released from activated neutrophils and binds to C1q and mannan-binding protein. Clin. Immunol. Immunopath. 72, 405-409.
15. Fearon, D.T. (1980). Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyte. J. Exp. Med. 152, 20-30.
16. Fearon, D.T., and Wong, W.W. (1983). Complement ligand-receptor interactions that mediate biological responses. Annu. Rev. Immunol. 1, 243-250.
17. Gertler, A., Grosclaude, J., Strasburger, C.J., Nir, S., and Djiane, J. (1996). Real-time kinetic measurements of the interactions between lactogenic hormones and prolactin-receptor extracellular domains from several species support the model of hormone-induced transient receptor dimerization. J. Biol.Chem. 271, 24482-24491.
18. Ghebrehiwet, B. (1988). Reversible biotinylation of C1q with a cleavable biotinyl derivative. J. Immunol. Meth. 110, 251-260.
19. Ghebrehiwet, B., and Hamburger, M. (1982). Purification and partial characterization of a C1q inhibitor from the membranes of human peripheral blood lymphocytes. J. Immunol. 129, 157-162.
20. Ghebrehiwet, B., and Peerschke, E.I. (1993). The C1q-R participates in immunoregulation and signal transduction. Behring Inst. Mitt. 93, 236-240.
21. Ghebrehiwet, B., Peerschke, E.I.B., Hong, Y., Munoz, P., and Gorevic, P.D. (1992). Short amino acid sequences derived from C1q receptor (C1q-R) show homology with the alpha chains of fibronectin and vitronectin receptors and collagen type IV. J. Leuk. Biol. 51, 546-556.
22. Ghebrehiwet, B., Silvestri, L., and McDevitt, C. (1984). Identification of the Raji cell membrane-derived C1q inhibitor as a receptor for human C1q. Purification and immunochemical characterization. J. Exp. Med. 160, 1375-1389.
23. Groger, R.K., Morrow, D.M., and Tykocinski, M.L. (1989). Directional antisense and sense cDNA cloning using Epstein-Barr virus episomal expression vectors. Gene 81, 285-294.
24. Guan, E., Burgess, W.H., Robinson, S.L., Goodman, E.B., McTigue, K.J., and Tenner, A.J. (1991). Phagocytic cell molecules that bind the collagen-like region of C1q. J. Cell. Biol. 266, 20345-20355.
25. Hammer, C.H., Wirtz, G.H., Renfer, L., Gresham, H.D., and Tack, B.F. (1981). Large scale isolation of functionally active components of the human complement system. J. Biol. Chem. 256, 3995-4006.
26. Hebert, L.A. (1991). The clearance of immune complexes from the circulation of man and other primates. Am. J. Kidney Dis. 17, 352-361.
27. Hourcade, D., Holers, V.M., and Atkinson, J.P. (1989). The regulators of complement activation (RCA) gene cluster. Adv. Immunol. 45, 381-416.
28. Jack, R.M., Ezzell, R.M., Hartwiq, J., and Fearon, D.T. (1986). Differential interaction of the C3b/C4b receptor and MHC class I with the cytoskeleton of human neutrophils. J. Immunol. 137, 3996-4003.
29. Jack, R.M., Lowenstein, B.A., and Nicholson-Weller, A. (1994). Regulation of C1q receptor expression on human polymorphonuclear leukocytes. J. Immunol. 153, 262-269.
30. Jiang, H., Siegel, J.N., and Gewurz, H. (1991). Binding and complement activation by C-reactive protein via the collagen-like region of C1q and inhibition of these reactions by monoclonal antibodies to C-reactive protein and C1q. J. Immunol. 146, 2314-2330.
31. Johnsson, B., Lofas, S., and Lindquist, G. (1991). Immobilization of proteins to a carboxymethyldextran-modified gold surface for biospecific interaction analysis in surface plasmon resonance sensors. Anal. Biochem. 198, 268-277.
32. Journet, A., and Tosi, M. (1986). Cloning and sequencing of full-length cDNA encoding the precursor of human complement component C1r. Biochem. J. 240, 783-787.
33. Kishore, U., Sontheimer, R.D., Sastry, K.N., Zaner, K.S., Zappi, E.G., Hughes, G.R., Khamashta, M.A., Strong, P., Reid, K.B.M., and Eggleton, P. (1997). Release of calreticulin from neutrophils may alter C1q-mediated immune function. Biochem. J. 322, 543-550.
34. Klickstein, L.B., Bartow, T.J., Miletic, B., Rabson, L.D., Smith, J.A., and Fearon, D.T. (1988). Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis. J. Exp. Med. 168, 1699-1717.
35. Klickstein, L.B., Wong, W.W., Smith, J.A, Weis, J.H., Wilson, J.G., and Fearon, DT. (1987). Human C3b/C4b receptor (CR1). Demonstration of long homologous repeating domains that are composed of the short consensus repeats characteristic of C3/C4 binding proteins. J. Exp. Med. 165, 1095-1112.
36. Korb, L.C., and Ahearn, J.M. (1997). C1q binds directly and specificallyto surfaceblebs of apoptotic human keratinocytes. J. Immunol. 158, 4525-4528.
37. Krych, M., Hourcade, D., and Atkinson, J.P. (1991). Sites within the complement C3b/C4b receptor important for the specificity of ligand binding. Proc. Natl. Acad. Sci. USA 88, 4353-4357.
38. Lachmann, P.J. (1984). Inherited complement deficiencies. Philos. Trans. R. Soc. Lond. (Biol.) 306, 419-430.
39. Lepow, I.H., Naff, G.B., Todd, E.W., Pensky, J., and Hinz, C.F.J. (1963). Chromatographic resolution of the first component of human complement into three activities. J. Exp. Med. 117, 983-1008.
40. Leytus, S.P., Kurachi, K., Sakariassen, K.S., and Davie, E.W. (1986). Nucleotide sequence of the cDNA coding for human complement C1r. Biochemistry 25, 4855-4863.
41. Liberti, P.A., Bausch, D.M., and Baillie, R.D. (1981).The incorporation of high pH euglobulin precipitation in the isolation of C1q. J. Immunol. Meth. 40, 243-245.
42. Lozada, C., Levin, R.I., Huie, M., Hirschhorn, R., Naime, D., Whitlow, M., Recht, P.A., Golden, B., and Cronstein, B.N. (1995). Identification of C1q as the heat-labile serum cofactor required for immune complexes to stimulate endothelial expression of the adhesion molecules E-selectin and intercellular and vascular cell adhesion molecules 1. Proc. Natl. Acad. Sc. USA 92, 8378-8382.
43. Malhotra, R., Reid, K.M.B., and Sim, R. (1988). Studies on the isolation of human C1q-receptor. Biochem. Soc. Trans. 16, 735-736.
44. Malhotra, R., and Sim, R.B. (1989). Chemical and hydrodynamic characterization of the human leucocyte receptor for complement subcomponent C1q. Biochem. J. 262, 625-631.
45. Malhotra, R., Willis, A.C., Jensenius, J.-C., Jackson, J., and Sim, R.B. (1992). Structure and homology of human C1q receptor (collectin receptor). Immunol. 78, 341-348.
46. Matsumoto, A.K., Martin, D.R., Carter, R.H., Klickstein, L.B., Ahearn, J.M., and Fearon, D.T. (1993). Functional dissection of the CD21/ CD19/TAPA-1/Leu-13 complex of B lymphocytes. J. Exp. Med. 178, 1407-1417.
47. Nepomuceno, R.R., Henschen-Edman, A.H., Burgess, W.H., and Tenner, A.J. (1997). cDNA cloning and primary structure analysis of C1qRp, the human C1q/MBL/SPA receptor that mediates enhanced phagocytosis in vitro. Immunity 6, 119-129.
48. Paccaud, J.-P., Carpentier, J.-L., and Schifferli, J.A. (1990). Exudation induces clustering of CR1 receptors at the surface of human polymorphonuclear leukocytes. Biochem. Biophys. Res. Commun. 172, 1203-1208.
49. Paccaud, J.P., Carpentier, J.L., and Schifferli, J.A. (1988). Direct evidence of the clustered nature of complement receptors type 1 on the erythrocyte membrane. J. Immunol. 141, 3889-3894.
50. Peerschke, E.I.B., Malhotra, R., Ghebrehiwet, B., Reid, K.B.M., Willis, A.C., and Sim, R.B. (1993). Isolation of a human endothelial cell C1q receptor. J. Leuk. Biol. 53, 179-184.
51. Petry, F., Berkel, A.I., and Loos, M. (1997). Multiple identification of a particular type of hereditary C1q deficiency in the Turkish population: review of the cases and additional genetic and functional analysis. Hum. Genet. 100, 51-56.
52. Petty, H.R., Smith, L.M., Fearon, D.T., and McConnell, H.M. (1980). Lateral distribution and diffusion of the C3b receptor of complement, HLAantigens, and lipid probes in peripheral blood leukocytes. Proc. Natl. Acad. Sci. USA 77, 6587-6591.
53. Reid, K.B.M. (1976). Isolation, by partial pepsin digestion, of the three collagen-like regions present in subcomponent C1q of the first component of human complement. Biochem. J. 155, 5-17.
54. Reilly, B.D., Makrides, S.C., Ford, P.J., Marsh, H.C.J., and Mold, C. (1994). Quantitative analysis of C4b dimer binding to distinct sites on the C3b/C4b receptor (CR1). J. Biol. Chem. 269, 7696-7701.
55. Shaw, S., Luce, G.G., Gilks, W.R., Anderson, K., Ault, K., Bochner, B.S., Boumsell, L., Denning, S.M., Engleman, E.G., Fleisher, T., et al. (1995). BP1.3 leucocyte differentiation antigen database. In Leucocyte Typing V, Schlossman, S.F., Boumsell, L., Gilks, W., Harlan, J.M., Kishimoto, T., Morimoto, C., Ritz, J., Shaw, S., Silverstein, R., Springer, T., et al., eds. (Oxford: Oxford University Press), p. 87.
56. 2 tetramers. Mol. Immunol. 20, 53-66.
57. Storm, D., Loos, M., and Kaul, M. (1996). Biotinylation of proteins via amino groups can induce binding to U937 cells, HL-60 cells, monocytes and granulocytes. J. Immunol. Meth. 199, 87-99.
58. Stuart, G.R., Lynch, N.J., Lu, J., Geick, A., Moffatt, B.E., Sim, R.B., and Schwaeble, W.J. (1996). Localisation of the C1q binding site within C1q receptor/calreticulin. FEBS Lett. 397, 245-249.
59. Tenner, A.J. (1993). Functional aspects of the C1q receptors. Behring Inst. Mitt. 93, 241-253.
60. Tenner, A.J., and Cooper, N.R. (1980). Analysis of receptor-mediated C1q binding to human peripheral blood mononuclear cells. J. Immunol. 125, 1658-1664.
61. Tenner, A.J., and Cooper, N.R. (1981a). Identification of types of cells in human peripheral blood that bind C1q. J. Immunol. 126, 1174-1179.
62. Tenner, A.J., Lesavre, P.M., and Cooper, N.R. (1981b). Purification and radiolabeling of human C1q. J. Immunol. 127, 648-653.
63. Tenner, A.J., Ziccardi, R.J., and Cooper, N.R. (1984). Antibody-independent C1 activation by E. coli. J. Immunol. 133, 886-891.
64. Terkeltaub, R., Tenner, A.J., Kozin, F., and Ginsberg, M.H. (1983). Plasma protein binding by monosodium urate crystals. Arthritis Rheum. 26, 775-783.
65. Tosi, M., Duponchel, C., Meo, T., and Julier, C. (1987). Complete cDNA sequence of human complement C1 s and close physical linkage of the homologous genes C1s and C1r. Biochem. 26, 8516-8524.
66. Tseng, Y., Zavodszky, P., and Schumaker, V.N. (1997). The human complement C1 complex has a picomolar dissociation constant at room temperature. J. Immunol. 158, 937-944.
67. Tuveson, D.A., Ahearn, J.M., Matsumoto, A.K., and Fearon, D.T. (1991). Molecular interactions of complement receptors on B lymphocytes: a CR1/CR2 complex distinct from CR2/CD19 complex. J. Exp. Med. 173, 1083-1089.
68. Uwatoko, S., and Mannick, M. (1990). The location of binding sites on C1q for DNA. J. Immunol. 144, 3484-3488.
69. Vanguri, P., Koski, C.L., Silverman, B., and Shin, M.L. (1982). Complement activation by isolated myelin: activation of the classical pathway in the absence of myelin-specific antibodies. Proc. Natl. Acad. Sci. USA 79, 3290-3294.
70. Wysocki, L.J., and Sato, V.L. (1978). "Panning" for lymphocytes: a method forcell selection. Proc. Natl. Acad. Sci. USA 75, 2844-2848.
71. Ying, S.C., Gewurz, A.T., Jiang, H., and Gewurz, H. (1993). Human serum amyloid P component oligomers bind and activate the classical complement pathway via residues 14-26 and 76-92 of the A chain collagen-like region of C1q. J. Immunol. 150, 169-176.
72. Yoon, S., and Fearon, D.T. (1985). Characterization of a soluble form of the C3b/C4b receptor (CR1) in human plasma. J. Immunol. 134, 3332-3338.
73. Zhang, S.C., Schultz, D.R., and Ryan, U.S. (1986). Receptor-mediated binding of C1q on pulmonary endothelial cells. Tissue Cell 18, 13-18.